Nonbenzamidine tetrazole derivatives as factor Xa inhibitors
- 24 December 2002
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 13 (3) , 369-373
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- The Design and Synthesis of Noncovalent Factor Xa InhibitorsCurrent Topics in Medicinal Chemistry, 2001
- Recent advances in Factor Xa inhibitorsExpert Opinion on Therapeutic Patents, 2001
- Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic coreBioorganic & Medicinal Chemistry Letters, 2001
- Perspectives on Factor Xa InhibitionCurrent Medicinal Chemistry, 2001
- Discovery of 1-[3-(Aminomethyl)phenyl]-N-[3-fluoro-2‘-(methylsulfonyl)- [1,1‘-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a Highly Potent, Selective, and Orally Bioavailable Inhibitor of Blood Coagulation Factor XaJournal of Medicinal Chemistry, 2001
- Crystal Structures of Human Factor Xa Complexed with Potent InhibitorsJournal of Medicinal Chemistry, 2000
- Design and Synthesis of Isoxazoline Derivatives as Factor Xa Inhibitors. 1Journal of Medicinal Chemistry, 1999
- (N-acyl-N-alkyl)glycyl borolysine analogs: A new class of potent thrombin inhibitorsBioorganic & Medicinal Chemistry Letters, 1996
- Structure of the hirugen and hirulog 1 complexes of α-thrombinJournal of Molecular Biology, 1991
- Optimization of conditions for the catalytic effect of the factor IXa - Factor VIII complexThrombosis Research, 1979